⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Merck Animal Health to Acquire TARGAN
businesswire.com
MRK
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
prnewswire.com
MRK
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
prnewswire.com
MRK
BioInvent's TNFR2 Antibody BI-1808 Delivers Meaningful Responses and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026)
accessnewswire.com
MRK
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
globenewswire.com
NVS
TLX
PFE
EXEL
LLY
XNCR
BTE
ORIC
MRK
ABBV
BMY
AZN
AMGN
Lupus Nephritis Clinical Trial Landscape Becomes Increasingly Crowded with 30+ Pharma Companies | DelveInsight
globenewswire.com
AZN
NVS
ABBV
BMY
GILD
REGN
VRTX
BIIB
JNJ
MRK
ARWR
TAK
VERA
SmithRx Launches Best-in-Class Partner Ecosystem to Help Employers Deliver Sustainable and Clinically Appropriate GLP-1 Programs at Scale
prnewswire.com
MRK
The Hashgraph Group and Merck Introduce EU Digital Product Passport on Hedera for Regulated Supply Chains
prnewswire.com
MRK
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
businesswire.com
GILD
MRK
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
businesswire.com
GILD
MRK